iodixanol has been researched along with Pulmonary Embolism in 15 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " One hundred and thirty patients (54 male; mean age, 52 years) clinically suspected of having pulmonary embolism were referred for pulmonary CT angiography and were randomly assigned to receive 80 mL of either iopamidol (370 mg of iodine per milliliter, n = 63) or iodixanol (320 mg of iodine per milliliter, n = 67) at a rate of 4 mL/sec." | 5.15 | Comparison of the effect of low- and iso-osmolar contrast agents on heart rate during chest CT angiography: results of a prospective randomized multicenter study. ( Bhalla, S; Chartrand-Lefebvre, C; Chughtai, AR; Mayo-Smith, WW; Ozkan, OS; Prenovault, J; Soto, JA; Soulez, G; Vydareny, KH; White, CS, 2011) |
| "To compare iomeprol 400 and iodixanol 320 in pulmonary artery MDCTA in subjects with suspected pulmonary embolism." | 5.14 | MDCT angiography for detection of pulmonary emboli: comparison between equi-iodine doses of iomeprol 400 mgI/mL and iodixanol 320 mgI/mL. ( Friedrich, K; Herold, C; Langenberger, H; Matzek, W; Plank, C; Schaefer-Prokop, C; Storto, ML; Wolf, F, 2009) |
| "We report a patient suspected of having pulmonary embolism, in whom a preexisting unilateral arteriovenous malformation prevented adequate evaluation of the pulmonary circulation." | 1.38 | Contralateral decubitus positioning enhances computed tomographic angiographic evaluation of pulmonary vasculature in a patient with a pulmonary arteriovenous malformation. ( Barack, BM; Berenji, GR; Santiago, S; Tafti, BA, 2012) |
| "In diagnosing acute pulmonary embolism (PE) in azotemic patients, scintigraphy and magnetic resonance imaging are frequently inconclusive or not available in many hospitals." | 1.35 | Minimizing contrast medium doses to diagnose pulmonary embolism with 80-kVp multidetector computed tomography in azotemic patients. ( Björk, J; Hansson, K; Holmquist, F; Nyman, U; Pasquariello, F, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, J | 1 |
| Lin, T | 1 |
| Fishman, EK | 1 |
| Johnson, PT | 1 |
| Chen, YA | 1 |
| Gray, BG | 1 |
| Bandiera, G | 1 |
| MacKinnon, D | 1 |
| Deva, DP | 1 |
| Holmquist, F | 1 |
| Hansson, K | 1 |
| Pasquariello, F | 1 |
| Björk, J | 1 |
| Nyman, U | 3 |
| Björkdahl, P | 2 |
| Chartrand-Lefebvre, C | 1 |
| White, CS | 1 |
| Bhalla, S | 1 |
| Mayo-Smith, WW | 1 |
| Prenovault, J | 1 |
| Vydareny, KH | 1 |
| Soto, JA | 1 |
| Ozkan, OS | 1 |
| Chughtai, AR | 1 |
| Soulez, G | 1 |
| Tafti, BA | 1 |
| Berenji, GR | 1 |
| Santiago, S | 1 |
| Barack, BM | 2 |
| Olsson, ML | 1 |
| Gunnarsson, M | 1 |
| Goldman, B | 1 |
| Faggioni, L | 1 |
| Neri, E | 1 |
| Sbragia, P | 1 |
| Pascale, R | 1 |
| D'Errico, L | 1 |
| Caramella, D | 1 |
| Bartolozzi, C | 1 |
| Wu, CC | 1 |
| Lee, EW | 1 |
| Suh, RD | 1 |
| Levine, BS | 1 |
| Narayan, A | 1 |
| Eng, J | 1 |
| Carmi, L | 1 |
| McGrane, S | 1 |
| Ahmed, M | 1 |
| Sharrett, AR | 1 |
| Streiff, M | 1 |
| Coresh, J | 1 |
| Powe, N | 1 |
| Hong, K | 1 |
| Laugharne, MJ | 1 |
| Paravasthu, M | 1 |
| Preston, A | 1 |
| Hill, KO | 1 |
| Horton, KM | 1 |
| Goodman, LR | 1 |
| Gulsun, M | 1 |
| Nagy, P | 1 |
| Washington, L | 1 |
| Bédard, JP | 1 |
| Blais, C | 1 |
| Patenaude, YG | 1 |
| Monga, E | 1 |
| Langenberger, H | 1 |
| Friedrich, K | 1 |
| Plank, C | 1 |
| Matzek, W | 1 |
| Wolf, F | 1 |
| Storto, ML | 1 |
| Schaefer-Prokop, C | 1 |
| Herold, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Does Reduction in Contrast Administration Dose in Computed Tomography Arteriograms Degrade Image Quality? A Single Institutional Review of an Ultra-low Contrast Dose Protocol[NCT02669784] | 34 participants (Actual) | Interventional | 2016-02-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. Measurement was taken at the ascending aorta near the sinotubular junction. (NCT02669784)
Timeframe: At 30 days
| Intervention | Hounsfield units (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (40mL) | 246.4 |
| Contrast (Omnipaque) Low Dose (50mL) | 287.5 |
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the distal abdominal aorta prior to the bifurcation. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (40mL) | 336.2 |
| Contrast (Omnipaque) Low Dose (50mL) | 321.2 |
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the proximal abdominal aorta at the level of the celiac axis. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (40mL) | 243.8 |
| Contrast (Omnipaque) Low Dose (50mL) | 329.5 |
"5 Point Grading Scale was used to determine CTA Vessel Opacification by a Board Certified Radiologist.~Poor opacification with no difference in attenuation of the lumen compared to the wall of the vessel. Non diagnostic.~Decreased opacification. Little to no difference in attenuation between the lumen and the wall. Non diagnostic.~Moderate opacification of the lumen of the vessel. Diagnostic study.~Good opacification of the lumen of the vessel.~Excellent opacification of the lumen of the vessel with distinct difference in attenuation of the wall and lumen of the vessel." (NCT02669784)
Timeframe: 30 days
| Intervention | score on a scale (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (40mL) | 4 |
| Contrast (Omnipaque) Low Dose (50mL) | 4.3 |
"5 Point Grading Scale was used to determine CTA Vessel Opacification by a second Board Certified Radiologist.~Poor opacification with no difference in attenuation of the lumen compared to the wall of the vessel. Non diagnostic.~Decreased opacification. Little to no difference in attenuation between the lumen and the wall. Non diagnostic.~Moderate opacification of the lumen of the vessel. Diagnostic~Good opacification of the lumen of the vessel.~Excellent opacification of the lumen of the vessel with distinct difference in attenuation of the wall and lumen of the vessel." (NCT02669784)
Timeframe: 30 days
| Intervention | score on a scale (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (40mL) | 4.2 |
| Contrast (Omnipaque) Low Dose (50mL) | 4.4 |
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the distal abdominal aorta prior to the bifurcation. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (40mL) | 261.9 |
| Contrast (Omnipaque) Low Dose (50mL) | 312.8 |
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the right common femoral artery. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (50mL) | 309.5 |
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the right common femoral artery. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|---|
| Contrast (Omnipaque) Low Dose (50mL) | 314.5 |
3 trials available for iodixanol and Pulmonary Embolism
| Article | Year |
|---|---|
Comparison of the effect of low- and iso-osmolar contrast agents on heart rate during chest CT angiography: results of a prospective randomized multicenter study.
Topics: Chi-Square Distribution; Contrast Media; Coronary Angiography; Double-Blind Method; Electrocardiogra | 2011 |
Pulmonary embolism: prospective comparison of iso-osmolar and low-osmolarity nonionic contrast agents for contrast enhancement at CT angiography.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Chi-Square Distribution; Contrast Media; Double-Blind M | 2005 |
MDCT angiography for detection of pulmonary emboli: comparison between equi-iodine doses of iomeprol 400 mgI/mL and iodixanol 320 mgI/mL.
Topics: Aged; Angiography; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Iopamidol; Male | 2009 |
12 other studies available for iodixanol and Pulmonary Embolism
| Article | Year |
|---|---|
Pulmonary CTA in sickle cell patients: quantitative assessment of enhancement quality.
Topics: Adult; Anemia, Sickle Cell; Case-Control Studies; Computed Tomography Angiography; Contrast Media; F | 2017 |
Variation in the utilization and positivity rates of CT pulmonary angiography among emergency physicians at a tertiary academic emergency department.
Topics: Adult; Aged; Angiography; Contrast Media; Cross-Sectional Studies; Emergency Service, Hospital; Fema | 2015 |
Minimizing contrast medium doses to diagnose pulmonary embolism with 80-kVp multidetector computed tomography in azotemic patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Azotemia; Contrast Media; Female; Humans; Linear Mode | 2009 |
Using 100- instead of 120-kVp computed tomography to diagnose pulmonary embolism almost halves the radiation dose with preserved diagnostic quality.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Male; Middle Aged; Phantoms, Imaging | 2010 |
Contralateral decubitus positioning enhances computed tomographic angiographic evaluation of pulmonary vasculature in a patient with a pulmonary arteriovenous malformation.
Topics: Aged; Arteriovenous Malformations; Contrast Media; Diagnosis, Differential; Humans; Male; Patient Po | 2012 |
Low-dose radiation with 80-kVp computed tomography to diagnose pulmonary embolism: a feasibility study.
Topics: Contrast Media; Feasibility Studies; Humans; Monte Carlo Method; Phantoms, Imaging; Pulmonary Emboli | 2012 |
80-kV pulmonary CT angiography with 40 mL of iodinated contrast material in lean patients: comparison of vascular enhancement with iodixanol (320 mg I/mL)and iomeprol (400 mg I/mL).
Topics: Aged; Aged, 80 and over; Angiography; Body Mass Index; Carcinoma, Non-Small-Cell Lung; Contrast Medi | 2012 |
Pulmonary 64-MDCT angiography with 30 mL of IV contrast material: vascular enhancement and image quality.
Topics: Aged; Algorithms; Angiography; Contrast Media; Female; Humans; Male; Pulmonary Embolism; Radiographi | 2012 |
Iliac vein compression as risk factor for left- versus right-sided deep venous thrombosis: case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Chi-Square Distribution; Child; Co | 2012 |
CT pulmonary angiography in elderly patients: outcomes in patients aged >85 years.
Topics: Age Factors; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Male; Patient Safety; Pulmo | 2013 |
How we do it: pulmonary embolism.
Topics: Contrast Media; Humans; Pulmonary Embolism; Tomography Scanners, X-Ray Computed; Tomography, X-Ray C | 2002 |
CT of deep venous thrombosis and pulmonary embolus: does iso-osmolar contrast agent improve vascular opacification?
Topics: Adult; Aged; Aged, 80 and over; Angiography; Contrast Media; Female; Humans; Image Processing, Compu | 2005 |